High-throughput sequencing was performed with a custom panel of 1031 genes.
Nine candidate genetic variants were identified in patients with type 1 AIP.
Eight candidate genetic variants were identified in patients with relapse of AIP.
Two candidate genes were identified in patients with extra-pancreatic lesions.